Harald Siedentop

2.4k total citations
14 papers, 429 citations indexed

About

Harald Siedentop is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Orthopedics and Sports Medicine. According to data from OpenAlex, Harald Siedentop has authored 14 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Orthopedics and Sports Medicine. Recurrent topics in Harald Siedentop's work include Total Knee Arthroplasty Outcomes (3 papers), Bone and Joint Diseases (3 papers) and Statistical Methods in Clinical Trials (3 papers). Harald Siedentop is often cited by papers focused on Total Knee Arthroplasty Outcomes (3 papers), Bone and Joint Diseases (3 papers) and Statistical Methods in Clinical Trials (3 papers). Harald Siedentop collaborates with scholars based in Germany, United States and Denmark. Harald Siedentop's co-authors include N Aigner, Marius E. Mayerhoefer, Josef Kramer, R Meizer, Oke Gerke, M. Breitenseher, Roy A.E. Bakay, Wilhelm Eisner, Rüdiger von Kummer and Rupert Sandbrink and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Neurology and Statistics in Medicine.

In The Last Decade

Harald Siedentop

14 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harald Siedentop Germany 10 103 88 87 84 62 14 429
Hirokazu Kondo Japan 17 184 1.8× 392 4.5× 181 2.1× 42 0.5× 49 0.8× 77 820
Constantine Farmakidis United States 10 123 1.2× 80 0.9× 90 1.0× 51 0.6× 53 0.9× 21 577
Ulla Engel Denmark 13 127 1.2× 12 0.1× 90 1.0× 21 0.3× 73 1.2× 30 488
Xin Qing United States 14 139 1.3× 103 1.2× 112 1.3× 14 0.2× 105 1.7× 56 597
Paul Lee United States 16 67 0.7× 14 0.2× 274 3.1× 52 0.6× 65 1.0× 40 498
Søren Dalager Denmark 11 66 0.6× 267 3.0× 150 1.7× 20 0.2× 13 0.2× 15 535
Ji Yeon Park South Korea 12 132 1.3× 23 0.3× 109 1.3× 38 0.5× 22 0.4× 48 535
Guangcheng Zhang China 11 110 1.1× 12 0.1× 191 2.2× 103 1.2× 60 1.0× 27 520

Countries citing papers authored by Harald Siedentop

Since Specialization
Citations

This map shows the geographic impact of Harald Siedentop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Siedentop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Siedentop more than expected).

Fields of papers citing papers by Harald Siedentop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Siedentop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Siedentop. The network helps show where Harald Siedentop may publish in the future.

Co-authorship network of co-authors of Harald Siedentop

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Siedentop. A scholar is included among the top collaborators of Harald Siedentop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Siedentop. Harald Siedentop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rao, Vishal N., Derek D. Cyr, Lisa Wruck, et al.. (2023). Electronic health record characterization and outcomes of heart failure with preserved ejection fraction. American Heart Journal. 263. 1–14. 1 indexed citations
2.
Schultheiß, Heinz‐Peter, Cornelia Piper, Olaf Sowade, et al.. (2016). Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy. Clinical Research in Cardiology. 105(9). 763–773. 89 indexed citations
3.
Brose, Marcia S., Christopher M. Nutting, Barbara Jarząb, et al.. (2013). Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial.. Journal of Clinical Oncology. 31(15_suppl). 4–4. 61 indexed citations
4.
Brose, Marcia S., Christopher M. Nutting, Barbara Jarząb, et al.. (2013). Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial.. Journal of Clinical Oncology. 31(18_suppl). 4–4. 41 indexed citations
5.
6.
Gerlinger, Christoph, Harald Siedentop, Oke Gerke, Ilka Schellschmidt, & Jan Endrikat. (2011). Optimal dose de-escalation trial designs for novel contraceptives in women. Computational Statistics & Data Analysis. 56(5). 1061–1068. 1 indexed citations
7.
Mondritzki, Thomas, Peter Kolkhof, Hani N. Sabbah, et al.. (2010). Differentiation of Arginine Vasopressin Antagonistic Effects by Selective V2 versus Dual V2/V1a Receptor Blockade in a Preclinical Heart Failure Model. American Journal of Therapeutics. 18(1). 31–37. 14 indexed citations
8.
Mayerhoefer, Marius E., Josef Kramer, M. Breitenseher, et al.. (2008). MRI-Demonstrated Outcome of Subchondral Stress Fractures of the Knee After Treatment with Iloprost or Tramadol: Observations in 14 Patients. Clinical Journal of Sport Medicine. 18(4). 358–362. 12 indexed citations
9.
Gerke, Oke & Harald Siedentop. (2008). Authors' rejoinder to ‘Dose‐escalation designs in oncology: ADEPT and the CRM’. Statistics in Medicine. 27(26). 5354–5355. 1 indexed citations
10.
Mayerhoefer, Marius E., Josef Kramer, M. Breitenseher, et al.. (2007). Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients. Lara D. Veeken. 46(9). 1460–1465. 36 indexed citations
11.
Gerke, Oke & Harald Siedentop. (2007). Optimal phase I dose‐escalation trial designs in oncology—A simulation study. Statistics in Medicine. 27(26). 5329–5344. 14 indexed citations
12.
Mayerhoefer, Marius E., M. Breitenseher, Siegfried Hofmann, et al.. (2004). Computer-Assisted Quantitative Analysis of Bone Marrow Edema of the Knee: Initial Experience with a New Method. American Journal of Roentgenology. 182(6). 1399–1403. 23 indexed citations
13.
Rychlik, Reinhard, et al.. (2003). Cost-Effectiveness of Adjuvant Treatment with Acamprosate in Maintaining Abstinence in Alcohol Dependent Patients. European Addiction Research. 9(2). 59–64. 22 indexed citations
14.
Rychlik, Reinhard, et al.. (2001). [St. John's wort extract WS 5572 in minor to moderately severe depression. Effectiveness and tolerance of 600 and 1200 mg active ingredient daily].. PubMed. 119(3-4). 119–28. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirokazu Kondo Breakdown of academic impact, for papers by Constantine Farmakidis Breakdown of academic impact, for papers by Ulla Engel Breakdown of academic impact, for papers by Xin Qing Breakdown of academic impact, for papers by Paul Lee Breakdown of academic impact, for papers by Søren Dalager Breakdown of academic impact, for papers by Ji Yeon Park Breakdown of academic impact, for papers by Guangcheng Zhang
Rankless by CCL
2026